Man-made antibodies

Monoclonal antibodies can now be genetically engineered and endowed with new properties. In the future, gene technology could enable antigen-binding fragments to be made by exploiting repertoires of variable domain genes derived from immunized animals and expressed in bacteria. How readily can this approach be extended to production of 'in vitro' repertoires of variable domain genes, and obviate the immunization of animals?

[1]  M. N. Margolies,et al.  Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion. , 1987, Journal of immunology.

[2]  J. Ghrayeb,et al.  Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Kocks,et al.  Timing, Genetic Requirements and Functional Consequences of Somatic Hypermutation during B‐Cell Development , 1987, Immunological reviews.

[4]  J. Emtage,et al.  Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli. , 1984, Nucleic acids research.

[5]  D. Burton,et al.  Localization of the binding site for the human high-affinity Fc receptor on IgG , 1988, Nature.

[6]  Roger Ekins.  A shadow over immunoassay , 1989, Nature.

[7]  P. T. Jones,et al.  Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.

[8]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[9]  M. Surani,et al.  A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Milstein,et al.  The Dynamic Nature of the Antibody Repertoire , 1988, Immunological reviews.

[11]  Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Waldmann,et al.  REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H , 1988, The Lancet.

[13]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[14]  A. Silverstein.  History of immunology. , 1996 .

[15]  P. Ehrlich,et al.  Croonian lecture.—On immunity with special reference to cell life , 1900, Proceedings of the Royal Society of London.

[16]  A. Rees,et al.  Modelling of the combining sites of three anti‐lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope. , 1986, The EMBO journal.

[17]  L. J. Perry,et al.  Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Winter,et al.  The binding site for C1q on IgG , 1988, Nature.

[19]  J. Seidman,et al.  Construction and expression of a recombinant antibody-targeted plasminogen activator. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Haber,et al.  Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. , 1985, Journal of the American College of Cardiology.

[21]  M Levitt,et al.  A humanized antibody that binds to the interleukin 2 receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L M Amzel,et al.  Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution. , 1981, The Journal of biological chemistry.

[23]  K. D. Bagshawe,et al.  Antibody directed enzymes revive anti-cancer prodrugs concept. , 1987, British Journal of Cancer.

[24]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[25]  R. Bruccoleri,et al.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Lesk,et al.  Conformations of immunoglobulin hypervariable regions , 1989, Nature.

[27]  J. Rodwell,et al.  Linker Technology: Antibody-Mediated Delivery Systems , 1985, Bio/Technology.

[28]  J. Carlson,et al.  A new means of inducibly inactivating a cellular protein , 1988, Molecular and cellular biology.

[29]  J. Hoxie,et al.  A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. , 1989, The Journal of biological chemistry.

[30]  M. Neuberger,et al.  The immunogenicity of chimeric antibodies , 1989, The Journal of experimental medicine.

[31]  A. Perelson.  Immune Network Theory , 1989, Immunological reviews.

[32]  P. Schultz,et al.  Generation of a catalytic antibody by site-directed mutagenesis. , 1989, Science.

[33]  K. Luger,et al.  Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. , 1989, Science.

[34]  S. Morrison,et al.  Immunoglobulin gene expression in transformed lymphoid cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Lerner,et al.  Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Winter,et al.  Expression of an antibody Fv fragment in myeloma cells. , 1988, Journal of molecular biology.

[37]  A M Lesk,et al.  Computer-generated schematic diagrams of protein structures. , 1982, Science.

[38]  K. Fry,et al.  Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction. , 1989, Biochemical and biophysical research communications.

[39]  F. Buchegger,et al.  Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. , 1987, Cancer research.

[40]  J. Larrick,et al.  Direct cDNA cloning of the rearranged immunoglobulin variable region. , 1989, BioTechniques.

[41]  J. Weill,et al.  8 – Development of the Chicken Antibody Repertoire , 1989 .

[42]  T. Waldmann,et al.  A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin , 1989, Nature.

[43]  S. Rudikoff,et al.  Single amino acid substitution altering antigen-binding specificity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Milstein,et al.  Mutation Drift and Repertoire Shift in the Maturation of the Immune Response , 1987, Immunological reviews.

[45]  A. C. Cuello,et al.  [17] Bispecific monoclonal antibodies from hybrid hybridomas , 1986 .

[46]  L. Staudt,et al.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Milstein,et al.  A single-step procedure for cloning and selection of antibody-secreting hybridomas. , 1990, Journal of immunological methods.

[48]  C. Springer,et al.  A cytotoxic agent can be generated selectively at cancer sites. , 1988, British Journal of Cancer.

[49]  R. Glockshuber,et al.  A comparison of strategies to stabilize immunoglobulin Fv-fragments. , 1990, Biochemistry.

[50]  K. Rajewsky,et al.  Immunoglobulin V region variants in hybridoma cells. I. Isolation of a variant with altered idiotypic and antigen binding specificity. , 1982, EMBO Journal.

[51]  Cyrus Chothia,et al.  The 14th barrel rolls out , 1988, Nature.

[52]  Development of biologically active peptides based on antibody structure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. C. Cuello,et al.  Hybrid hybridomas and their use in immunohistochemistry , 1983, Nature.

[54]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[55]  Lutz Riechmann,et al.  Reshaping human antibodies for therapy , 1988, Nature.

[56]  G. Köhler,et al.  Frequency of expressed immunoglobulin light chain genes in lipopolysaccharide-stimulated BALB/c spleen cells , 1984, The Journal of experimental medicine.

[57]  S. Cabilly.  Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli. , 1989, Gene.

[58]  J. C. Cheetham,et al.  Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering , 1987, Nature.

[59]  D R Burton,et al.  Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. , 1989, Science.

[60]  M. Neuberger.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. , 1983, The EMBO journal.

[61]  R. R. Robinson,et al.  Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.

[62]  G. Inghirami,et al.  Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. , 1986, Science.

[63]  P. T. Jones,et al.  Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli , 1989, Nature.

[64]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[65]  C. Milstein,et al.  Somatic mutation and the maturation of immune response to 2-phenyl oxazolone , 1984, Nature.

[66]  K. D. Hardman,et al.  Single-chain antigen-binding proteins. , 1988, Science.

[67]  C. Kocks,et al.  Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. , 1989, Annual review of immunology.

[68]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[69]  Robert O. Fox,et al.  Recombinant antibodies possessing novel effector functions , 1984, Nature.

[70]  J N Weinstein,et al.  Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.

[71]  G. Winter,et al.  Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Neuberger,et al.  A hapten-specific chimaeric IgE antibody with human physiological effector function , 1985, Nature.

[73]  P G Schultz,et al.  Selective chemical catalysis by an antibody. , 1986, Science.

[74]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[75]  F. Wurm,et al.  Biological properties of a CD4 immunoadhesin , 1990, Nature.

[76]  R. Aalberse,et al.  Inhibition of complement activation by IgG4 antibodies. , 1986, Clinical and experimental immunology.

[77]  J Deisenhofer,et al.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. , 1980, Journal of molecular biology.

[78]  C. Milstein,et al.  Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.

[79]  J. D. Haynes,et al.  Specific basophil hypersensitivity induced by skin testing and transferred using immune serum , 1975, Nature.

[80]  P. T. Jones,et al.  Expression and Secretion of Repertoires of VH Domains in Escherichia Coli : Isolation of Antigen Binding Activities , 1989 .

[81]  T. Bhat,et al.  Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme. , 1990, Journal of molecular biology.